COX-2 mediated altered prostaglandin balance in diabetes complications

摘要

The subject invention concerns novel methods for determining an individual's risk of developing diabetes-related complications. An embodiment provides determining at the onset or prior to the onset of Type I diabetes those individuals with a high risk of developing diabetes-related complications. The subject invention also concerns therapeutic methods for inhibiting and/or preventing the development of diabetes-related complications prior to or at the onset of T1D.